EDAP TMS SA : EDAP Reports 2018 Third Quarter Results
(WorldNews Health)

Generated revenue growth of more than 14% as compared to the third quarter of 2017 Continued geographic expansion of Focal One with installations in Brazil and South Korea Since receiving FDA clearance for Focal One in June 2018, progressed through the lengthy capital equipment sales cycle with U.S. hospitals and health centers, and expect to announce agreements in the near-term Announced expiration of tranche of outstanding warrants underlying 3.3 million common shares on the form of ADRs LYON, France, November 14, 2018 -- EDAP TMS SA (Nasdaq: EDAP) (`the Company`), the global leader in therapeutic ultrasound, announced today financial results for the third quarter and nine-month period of...